Giuseppe Murdolo

Endocrinology — Azienda Ospedaliera di Perugia, Italy

LeadR Profile

Giuseppe Murdolo Azienda Ospedaliera di Perugia Italy
185 ScienceLeadR Reputation 185
Network Map

Endocrinology

Subspecialties: Biochemistry - Cardiology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Azienda Ospedaliera di Perugia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 61

Citations

Citations: 2 638 1st author: 21 Last author: 3 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The acute diabetic foot: different clinical patterns with a dedicated fast-track pathway.
diabetes mellitus, foot, ulcer, diabetic foot
Acta Diabetol20260
Integrated care pathway for the management of diabetic foot disease: a position statement from the Italian Diabetic Foot Study Group.
diabetes mellitus, foot, diabetic foot, therapeutics, foot diseases
Acta Diabetol20260
Therapeutic footwear in patients with diabetes: a position statement from the Italian diabetic foot study group.
diabetes mellitus, foot, prescriptions, ulcer, diabetic foot, therapeutics
Acta Diabetol20260
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
diabetes mellitus, lipoproteins, c-reactive protein, cardiovascular diseases, cholesterol, body weight, risk factors, therapeutics, heart disease risk factors, random allocation, triglycerides, pulse, diabetes mellitus, type 2, semaglutide
JAMA Cardiol20260
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.
diabetes mellitus, kidney diseases, heart failure, internal medicine, heart, kidney, drug-related side effects and adverse reactions, history, diabetes mellitus, type 2, semaglutide
JAMA Intern Med20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map